Cargando…
Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's Syndrome: a randomized, double-blind, placebo controlled cross-over study
BACKGROUND: Matrix metalloproteinases (MMPs) are proteolytic enzymes that may contribute to tissue destruction in Sjögren's syndrome (SS). Low-dose doxycycline (LDD) inhibits MMPs. We evaluated the efficacy of LDD for the subjective symptoms in primary SS patients. This was a randomized, double...
Autores principales: | Seitsalo, Hubertus, Niemelä, Raija K, Marinescu-Gava, Magdalena, Vuotila, Tuija, Tjäderhane, Leo, Salo, Tuula |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235889/ https://www.ncbi.nlm.nih.gov/pubmed/18163919 http://dx.doi.org/10.1186/1477-5751-6-11 |
Ejemplares similares
-
Low-Dose Doxycycline Treatment Normalizes Levels of Some Salivary Metabolites Associated with Oral Microbiota in Patients with Primary Sjögren’s Syndrome
por: Herrala, Maria, et al.
Publicado: (2021) -
Novel algorithms for LDD motif search
por: Xiao, Peng, et al.
Publicado: (2019) -
Effect of Ocimum sanctum L as LDD in periodontal therapy
por: Deepika, Burra Anand, et al.
Publicado: (2023) -
Oral Presentations (LDD, LPES, LNM, LPAT, LNT, LPPT, LPM)
Publicado: (2010) -
Chemical characterization and biological activity data for a novel indirubin derivative, LDD-1819
por: Kim, Woong-Hee, et al.
Publicado: (2019)